On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdaySep 12, 2017 3:53 pm

Algae Dynamics Corp. (ADYNF) Collaborating with Prominent Neuroscientist to Research Benefits of Cannabis Oil for Mental Health Disorders

Partnership between Algae Dynamics and Dr. Steven Laviolette focuses on medical benefits of cannabis and hemp oils for various mental health disorders Canada is moving to legalize cannabis throughout the country in 2018, which could radically change research playing field Canadian cannabis oil extraction market projected to reach $1.5 billion by 2020 Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company focused on the development of proprietary research and products derived from cannabis and hemp oils, has begun a collaborative relationship with one neuroscientist who is looking deep within the brain for answers to some of the world’s most pressing mental…

Continue Reading

TuesdaySep 12, 2017 2:55 pm

India Globalization Capital, Inc. (NYSE: IGC) Announces Alzheimer’s Drug Candidate Targeting Aβ Proteins

More than 5.3 million people in the U.S. have Alzheimer’s disease, which has no effective cure or substantial treatment India Globalization Capital’s IGC-ADI drug candidate targets proteins associated with the buildup of lesions in the brain The company acquired exclusive rights to a patent, based on University of South Florida studies supporting THC’s role in inhibiting Aβ plaque production Alzheimer’s disease now affects over 5.3 million people in the United States, imposing an estimated economic cost of $236 billion. There has been no effective treatment to slow down or reverse its effects. That may be about to change, as India…

Continue Reading

TuesdaySep 12, 2017 2:18 pm

ORHub’s (ORHB) Revolutionary Software Solution Could Help Pave the Way to Value-Based Healthcare in the US

ORHub is a pioneering cloud-based healthcare solution that can help medical providers eliminate inefficiencies, cut costs and improve quality of care ORHub has created a new category of healthcare IT vertical-specific software called surgical resource management (SRM) ORHub creates the largest source of intelligent surgical information in the world, opening up a vast pipeline of revenue opportunities ORHub is positioned to become the universal SRM platform for improving healthcare efficiency and cutting costs “Value-based healthcare” is a buzz phrase these days, and surgical procedures are at the center of the issue, with hospitals spending, on average, between 48 and 50…

Continue Reading

TuesdaySep 12, 2017 9:00 am

Alzheimer’s Disease: Cannabis Formulation Shows Promise

NetworkNewsWire Editorial Coverage: Known as America’s most expensive disease, with an estimated cost to the U.S. economy of $236 billion in 2016, Alzheimer’s disease (AD) affects more than 5.3 million Americans. Over the next 20 years, the number of those afflicted with the disease is expected to double. The forecast is staggering, considering that no effective cure has been found, but the quest for one continues, with India Globalization Capital, Inc. (NYSE: IGC) (IGC Profile), Anavex Life Sciences (NASDAQ: AVXL), Axovant Sciences (NYSE: AXON), AC Immune Ltd. (NASDAQ: ACIU) and Biogen, Inc. (NASDAQ: BIIB) all exploring a variety of approaches…

Continue Reading

TuesdaySep 12, 2017 9:00 am

Cannabis Biotechs Taking Leading Stance in Global Marijuana Market

With leading recent estimates clocking the 2016 North American legal cannabis market between $6.7 and $7.2 billion, the only thing more impressive about the industry is the growth projections. Research estimates a whopping compound annual sales growth rate of 25 percent through 2021. This stupendous growth, driven by more and more states adopting medical and even recreational legislation, has combined with the fact that the FDA has not yet approved any drug product containing or derived from botanical marijuana to create a perfect storm for cannabis biotechs like Vancouver-based InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) (IMLFF Profile) and GW…

Continue Reading

MondaySep 11, 2017 3:04 pm

AppSwarm, Inc. (SWRM) Focuses on Key Revenue Streams to Leverage its Growth Strategy

AppSwarm, Inc. reported $589,000 in revenue for 2016 and has continued to focus on growth in 2017 The company has focused on four key revenue streams to boost the success of social game development, mobile apps, and e-commerce websites A proprietary screening process enables it to select app ideas with the most potential, based on their benefits for developers, entrepreneurs, and consumers Earning $589,000 in revenue for 2016 hasn’t given AppSwarm, Inc. (OTC: SWRM) a reason to slow down. From in-house development to assets gained through mergers and acquisitions, the company has focused on a vigorous growth strategy centered on…

Continue Reading

MondaySep 11, 2017 9:33 am

SinglePoint, Inc. (SING) Acquires Dr. FeelGood; Plans in View for Multistate Brand Expansion

SinglePoint has completed its third acquisition of 2017 Company’s revenue has grown 378-fold since first quarter 2017 Delivery application in development will directly compete with Leafly and WeedMaps Company well-positioned to continue acquisition strategy and further increase revenue Marking its third acquisition of 2017, SinglePoint, Inc. (OTC: SING) announced on September 6 that it has acquired profitable cannabis distribution company Dr. FeelGood. According to the agreement terms, SinglePoint will acquire 51 percent of the company in a combination of cash and stock, allowing SinglePoint to recognize all revenue. This acquisition adds yet another revenue stream for SinglePoint, further affirming the…

Continue Reading

FridaySep 08, 2017 3:21 pm

ChineseInvestors.com, Inc. (CIIX) Aiming to Grow Direct-to-Consumer e-Commerce Business

Company engages Launch Haus LLC, a digital agency, to grow its direct-to-consumer e-commerce business through a new marketing campaign Consilium Global Research (http://nnw.fm/e5EiK) projects a CAGR of nearly 100% for CIIX through FY2020, with revenues reaching $14.8 million CIIX has goal of becoming the largest Chinese publicly traded company in the legalized cannabidiol (CBD) market, with a target audience of the global Chinese-speaking community ChineseInvestors.com, Inc.’s (OTCQB: CIIX) goal of growing its global sales of hemp-based cannabidiol (CBD) products will be aided by its engagement of Launch Haus LLC, a Scottsdale, Arizona-based holding company specializing in digital direct-to-consumer marketing and…

Continue Reading

ThursdaySep 07, 2017 4:08 pm

Moxian, Inc. (NASDAQ: MOXC) Shifts to Joint Venture Strategy in Effort to Penetrate Key Markets in China

Crystal Equity Research, encouraged by new joint venture strategy, forecasts rising revenue for Moxian (http://nnw.fm/8GWgi) Key to market growth is UnionPay’s payment module in Moxian+ app MOXC now targets larger $2-4 million businesses for Moxian+ Merchant app sales Moxian, Inc. (NASDAQ: MOXC) has changed its business strategy to grow more quickly within China, targeting the nation's top four markets while also beginning to utilize a joint venture strategy in order to penetrate these markets more efficiently with the aid of entrenched businesses. MOXC’s marketing and sales team members are now acting as sales managers, working with independent agents to secure…

Continue Reading

ThursdaySep 07, 2017 2:14 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Continues Showcasing Proprietary Research at Cannabis Investment Conferences

Proprietary Lexaria technology improves delivery of bioactive compounds in a variety of products, including cannabis-based gourmet foods Market predictions for the legal marijuana industry forecast $50 billion in sales by 2026 19 patent applications filed and pending in more than 40 countries Following a successful showing at the inaugural Institutional Capital & Cannabis Conference (IC3) in California earlier this month, Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) CEO Chris Bunka expects the company to be noticed by investors. Bunka’s presentation of the company’s latest technology slated to benefit the cannabis industry includes the world’s first clinical study on human volunteers of…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217